A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus

NCT06279234 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)
Obesity

Interventions

DRUG: Placebo
DRUG: Rosuvastatin
DRUG: Midazolam
DRUG: Omeprazole
DRUG: PF-06954522

Sponsor

Pfizer